Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VIVO Cannabis Inc. VVCIF

VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical... see more

OTCQB:VVCIF - Post Discussion

VIVO Cannabis Inc. > Vivo doing all the right things...but clearly a 2021 story
View:
Post by skibumm on Oct 04, 2020 10:04pm

Vivo doing all the right things...but clearly a 2021 story

lots of griping & complaining about the stock price, but face the facts. Vivo just diluted shareholder value 10% to partially settle debenture due...now has 328+M shares outstanding...and Laflamme owns a ton of them that he can dump on the market any time he wants. Vivo is still not profitable...no German licence...and Fishman has lots of other problems to deal with, one at a time. There is 50/50 chance imo that Vivo emerges as a winner in 2021...but I have a full position so I am banking on Fishman to deliver for the shareholders......1 thing Vivo did right is loan to CB2 Insite cbii/c, that was converted to 6.2M shares app .03....now valued at .24 and company showing lots of potential with telemed in US
Comment by LI4VESTREAM543 on Oct 05, 2020 12:39am
This post has been removed in accordance with Community Policy
Comment by Schaffhausen on Oct 05, 2020 7:24am
I'm not excited by eu gmp licensing. Vivo is building its presence in Germany without supplying feedstocks from Canada; thats what Linneo deal is for. Any fledgling Germany sales won't have high margin but who cares, that is not the primary goal as they work to develop the market and build branding. When EU GMP comes to Napanee likely in 2021 that will help in 2022 and beyond if Vivo has ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities